Raptor Pharmaceutical announces Phase 2b results of DR Cysteamine trial
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic ...
News-Medical-Net,
Mon Nov 23 04:25:22 PST 2009
Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
Found on Topix News